• Explore /
  • Poster
  • / Impact of immune-related adverse events on survival in patients with metastastic urothelial carcinoma treated with immune-checkpoint inhibitors.

Impact of immune-related adverse events on survival in patients with metastastic urothelial carcinoma treated with immune-checkpoint inhibitors.

Abstract Poster

Authors

Rafael Morales-Barrera, Sr

Rafael Morales-Barrera

Vall d'Hebron Institute, Barcelona, Spain

Rafael Morales-Barrera , Cristina Suarez Rodriguez , Macarena Gonzalez , Javier Ros , Maria Eugenia Semidey , Ester Serra Hernandez , Joaquin Mateo , Carlos Fernández Sáez , Fernando Lozano , Richard Mast , Sarai Roche , Angela Quintana , Sara Gutiérrez Fernández , Cesar Serrano , Claudia Valverde , Ines de Torres , Xavier Maldonado , Juan Morote , Joan Carles

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4531)

DOI

10.1200/JCO.2019.37.15_suppl.4531

Abstract #

4531

Poster Bd #

357

Abstract Disclosures

Similar Posters

First Author: Rohit K. Jain

First Author: Christoffer Gebhardt

First Author: Thierry Landre

First Author: Lorenzo Pilla